Drug Company Monopolies and Profits

ENGR.ECONOMIC ANALYSIS
14th Edition
ISBN:9780190931919
Author:NEWNAN
Publisher:NEWNAN
Chapter1: Making Economics Decisions
Section: Chapter Questions
Problem 1QTC
icon
Related questions
Question

read and answer mentioned question 

 

  1. Chapter 4: Ethics in Market Place (Page 212)

“Drug Company Monopolies and Profits”

being studied for
1. Is the drug industry a good illustration
of the market theories described in
this chapter? Explain your answer.
2. What changes, if any, do you think
we should make to U.S. drug patent
laws? Explain.
3. How should the relation between
drugs and human life/health affect
your views on drug industry monop-
oly profits? Explain.
Transcribed Image Text:being studied for 1. Is the drug industry a good illustration of the market theories described in this chapter? Explain your answer. 2. What changes, if any, do you think we should make to U.S. drug patent laws? Explain. 3. How should the relation between drugs and human life/health affect your views on drug industry monop- oly profits? Explain.
revenues into research, they siphon off 17 percent
its to cover the costs of research for new drugs. B
2008, average drug company profit rates wers
Financial Reports, in the first quarter of 2007 nd
According to the U.S. Census Bureau's Quartety
panies. Drug companies say they need these prof
3 times the average for other manufacturing com
in the first quarter of 2010, they averaged close to
average for all other manufacturing companies, and
drug company profit rates were close to 7 times the
ing companies. In the first quarter of 2009, aveg
about 3 times the average for all other manufad
rug companies in the United States are
granted a patent on any new pharmaceu-
tical drug they develop, which gives them
a monopoly on that drug for 20 years. Not surpris-
ingly, high monopoly profits (i.e., profits well be-
yond the average rate of profits in other industries)
are characteristic of the pharmaceutical industry. In
a 2003 study entitled The Other Drug War I, Pub-
lic Citizen's Congress Watch noted that during the
1970s and 1980s, drug companies in the Fortune 500
had average profit rates (as a percent of revenues)
that were double the average for all other industries
in the Fortune 500. During the 1990s, drug company
profit rates averaged 4 times the average profit rates
of all other industries, and during the first 5 years of
the twenty-first century, drug company profit rates
were about 3 times the rates of other industries.
D.
while drug companies put only 14 percent of the
of their revenues into dividends they hand o
shareholders and plow 31 percent into advertising
and administration. A study of drug manufactur
ing costs (see www.rense.com/general54/prece
htm) found that prescription drugs have markups d
5,000 percent, 30,000 percent, and 500,000 percen
over the cost of their ingredients. The ingredients n
100 tablets of Norvasc, which sold for $220, cost 4
cents; of Prozac, which sold for $247, 11 cents: of
Tenormin, which sold for $104, 13 cents; of Xanax
which sold for $136, 3 cents, and so on.
Transcribed Image Text:revenues into research, they siphon off 17 percent its to cover the costs of research for new drugs. B 2008, average drug company profit rates wers Financial Reports, in the first quarter of 2007 nd According to the U.S. Census Bureau's Quartety panies. Drug companies say they need these prof 3 times the average for other manufacturing com in the first quarter of 2010, they averaged close to average for all other manufacturing companies, and drug company profit rates were close to 7 times the ing companies. In the first quarter of 2009, aveg about 3 times the average for all other manufad rug companies in the United States are granted a patent on any new pharmaceu- tical drug they develop, which gives them a monopoly on that drug for 20 years. Not surpris- ingly, high monopoly profits (i.e., profits well be- yond the average rate of profits in other industries) are characteristic of the pharmaceutical industry. In a 2003 study entitled The Other Drug War I, Pub- lic Citizen's Congress Watch noted that during the 1970s and 1980s, drug companies in the Fortune 500 had average profit rates (as a percent of revenues) that were double the average for all other industries in the Fortune 500. During the 1990s, drug company profit rates averaged 4 times the average profit rates of all other industries, and during the first 5 years of the twenty-first century, drug company profit rates were about 3 times the rates of other industries. D. while drug companies put only 14 percent of the of their revenues into dividends they hand o shareholders and plow 31 percent into advertising and administration. A study of drug manufactur ing costs (see www.rense.com/general54/prece htm) found that prescription drugs have markups d 5,000 percent, 30,000 percent, and 500,000 percen over the cost of their ingredients. The ingredients n 100 tablets of Norvasc, which sold for $220, cost 4 cents; of Prozac, which sold for $247, 11 cents: of Tenormin, which sold for $104, 13 cents; of Xanax which sold for $136, 3 cents, and so on.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Public Policy
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, economics and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
ENGR.ECONOMIC ANALYSIS
ENGR.ECONOMIC ANALYSIS
Economics
ISBN:
9780190931919
Author:
NEWNAN
Publisher:
Oxford University Press
Principles of Economics (12th Edition)
Principles of Economics (12th Edition)
Economics
ISBN:
9780134078779
Author:
Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:
PEARSON
Engineering Economy (17th Edition)
Engineering Economy (17th Edition)
Economics
ISBN:
9780134870069
Author:
William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:
PEARSON
Principles of Economics (MindTap Course List)
Principles of Economics (MindTap Course List)
Economics
ISBN:
9781305585126
Author:
N. Gregory Mankiw
Publisher:
Cengage Learning
Managerial Economics: A Problem Solving Approach
Managerial Economics: A Problem Solving Approach
Economics
ISBN:
9781337106665
Author:
Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike Shor
Publisher:
Cengage Learning
Managerial Economics & Business Strategy (Mcgraw-…
Managerial Economics & Business Strategy (Mcgraw-…
Economics
ISBN:
9781259290619
Author:
Michael Baye, Jeff Prince
Publisher:
McGraw-Hill Education